Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders, published by SAGE PUBLICATIONS LTD, is an esteemed open-access journal dedicated to advancing knowledge in the field of rheumatology and related immunological disorders. Since its inception in 2008, the journal has provided a platform for researchers and clinicians from around the world to disseminate cutting-edge studies and insights into arthritis and musculoskeletal conditions. Based in New Zealand, this journal has maintained a commendable standing in academic circles, evidenced by its Q3 quartile rankings in both Immunology and Allergy and Rheumatology categories for 2023, alongside respectable Scopus rankings. The journal serves as a vital resource for healthcare professionals, researchers, and students, facilitating enhanced understanding and treatment of musculoskeletal disorders through high-quality research and peer-reviewed articles. With a focus on fostering interdisciplinary collaboration and innovation in the field, Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders is essential reading for those committed to improving patient outcomes and advancing scientific knowledge.

The International Journal of Rheumatology, published by HINDAWI LTD, serves as a vital resource for researchers and practitioners in the fields of rheumatology and immunology. Since its inception in 2009 as an Open Access journal, it has aimed to disseminate high-quality, peer-reviewed research to foster advancements in the understanding and treatment of rheumatic diseases. With an ISSN of 1687-9260 and E-ISSN of 1687-9279, the journal has become increasingly relevant, achieving a respectable Q3 ranking in both the Immunology and Rheumatology categories in 2023, and earning a Scopus rank of #27 out of 73 in Medicine Rheumatology. The journal's commitment to excellence is reflected in its wide-ranging scope, addressing current trends and innovations through empirical studies, reviews, and clinical insights. Its global readership, based in the United States and beyond, highlights the journal's importance in shaping the discourse within rheumatological research. As it converges through the years from 2010 to 2024, the International Journal of Rheumatology continues to be a cornerstone for sharing groundbreaking findings and fostering collaboration in the rheumatic disease community.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, published by Elsevier, stands as a premier journal in the field of rheumatology, holding a prestigious Q1 ranking in both Medicine (miscellaneous) and Rheumatology categories as of 2023. With an ISSN of 1521-6942 and an E-ISSN of 1521-1770, the journal is dedicated to advancing clinical knowledge and practice through the dissemination of high-quality, peer-reviewed research. Since its inception in 1995, this journal has provided a platform for researchers, clinicians, and healthcare providers to share significant advancements, best practices, and innovative insights that shape the standards of care in rheumatology. The commitment to open access publishing reflects its mission to broaden the reach of critical research findings, ensuring that professionals across the globe can access valuable information in this vital field. The journal's impressive Scopus ranking, positioned at #10 out of 73 in Medicine-Rheumatology, alongside its notable impact factor, underscores its importance and influence in guiding clinical practice and policy in rheumatologic conditions. By engaging with this journal, readers can stay informed about emerging trends and evidence-based strategies that are crucial for improving patient outcomes.

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

The Scandinavian Journal of Rheumatology, published by Taylor & Francis Ltd, is a prestigious peer-reviewed journal dedicated to advancing research in the fields of rheumatology, immunology, and related disciplines. With an ISSN of 0300-9742 and an E-ISSN of 1502-7732, this journal has established itself as a vital platform for disseminating significant findings and innovative approaches in the management of rheumatic diseases since its inception in 1959. As a recognized scholarly outlet, it currently resides within the Q2 category for Medicine (miscellaneous) and ranks #39 out of 73 in Rheumatology according to the 2023 Scopus assessments. This reflects the journal's commitment to high-quality research and its relevance in the scientific community. Although it does not provide Open Access options, the journal's rigorous selection process ensures that only the most impactful research reaches its audience, making it a crucial resource for researchers, clinicians, and students engaged in the exploration of rheumatological and immunological challenges. The journal's broad scope encompasses ongoing studies, clinical trials, and reviews that aim to enhance understanding and treatment of rheumatic conditions, promoting collaboration and knowledge-sharing among professionals in the field.

Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.